0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Glycopeptides"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Glycopeptide Antibiotics Market Report 2025 - Product Thumbnail Image

Glycopeptide Antibiotics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Antibiotic Resistance Market Report 2025 - Product Thumbnail Image

Antibiotic Resistance Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Antibiotics Market Report 2025 - Product Thumbnail Image

Antibiotics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Vancomycin Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Vancomycin Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
EUR$2,750USDGBP
From
EUR$4,750USDGBP
Antibiotic Drug Resistance. Edition No. 1 - Product Thumbnail Image

Antibiotic Drug Resistance. Edition No. 1

  • Book
  • October 2019
  • 720 Pages
EUR$323USDGBP
EUR$99USDGBP
Antibiotics and Antibiotic Resistance. Edition No. 1 - Product Thumbnail Image

Antibiotics and Antibiotic Resistance. Edition No. 1

  • Book
  • November 2011
  • 224 Pages
EUR$99USDGBP
  • 13 Results (Page 1 of 1)
Loading Indicator

Glycopeptides are a class of antibiotics used to treat serious bacterial infections. They are derived from a polysaccharide-peptide backbone and are effective against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Glycopeptides are typically used in combination with other antibiotics to treat infections that are resistant to other antibiotics. They are also used to prevent infections in patients who are immunocompromised or undergoing surgery. Glycopeptides are generally more expensive than other antibiotics, and their use is limited due to their narrow spectrum of activity. However, they are an important part of the antibiotic arsenal and are used in cases where other antibiotics are ineffective. Some companies in the glycopeptides market include Merck, Pfizer, AstraZeneca, and GlaxoSmithKline. Show Less Read more